Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page
- Check5 days agoChange DetectedRecruitment status is updated to No longer looking for participants, reflecting that participant enrollment has ended. The page also adds new user-facing sections (How to Read a Study Record, Common Questions, How to Join a Study), reformats the Intervention/Treatment heading, and lists Revision: v3.6.0 as the current version.SummaryDifference0.3%

- Check12 days agoChange DetectedThe page's revision label was updated to v3.5.5, representing a minor version update to the page. This does not modify the study details or visible content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLakefront Biotherapeutics NV has been added to the Collaborators and Investigators section, and Galapagos NV has been removed. This reflects changes in collaboration and may affect attribution and the points of contact for the trial.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, reflecting a software/template update rather than a change to the study details or content.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision from v3.5.2 to v3.5.3 indicates a small update to the page version. There is no visible change to the study details or content shown in the provided data.SummaryDifference0.0%

- Check55 days agoChange DetectedUpdated the displayed collaborator name formatting from **“Ono Pharmaceutical Co. Ltd”** to **“Ono Pharmaceutical Co., Ltd.”**SummaryDifference0.0%

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.